DK57391D0 - HIV PROTEINS AND PEPTIDES FOR USE IN DIAGNOSTICATION, PROPHYLAXY AND TREATMENT OF AIDS - Google Patents

HIV PROTEINS AND PEPTIDES FOR USE IN DIAGNOSTICATION, PROPHYLAXY AND TREATMENT OF AIDS

Info

Publication number
DK57391D0
DK57391D0 DK91573A DK57391A DK57391D0 DK 57391 D0 DK57391 D0 DK 57391D0 DK 91573 A DK91573 A DK 91573A DK 57391 A DK57391 A DK 57391A DK 57391 D0 DK57391 D0 DK 57391D0
Authority
DK
Denmark
Prior art keywords
diagnostication
prophylaxy
peptides
aids
treatment
Prior art date
Application number
DK91573A
Other languages
Danish (da)
Other versions
DK57391A (en
Inventor
James R Rusche
Scott D Putney
Kashayar Javaherian
John Farley
Raymond Grimaila
Debra Lynn
Joan Petro-Breyer
Thomas O'keeffe
Gregory Larosa
Albert T Profy
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of DK57391D0 publication Critical patent/DK57391D0/en
Publication of DK57391A publication Critical patent/DK57391A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK057391A 1988-10-03 1991-04-02 HIV PROTEINS AND PEPTIDES FOR USE IN DIAGNOSTICATION, PROPHYLAXY AND TREATMENT OF AIDS DK57391A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25294988A 1988-10-03 1988-10-03
US35954389A 1989-06-01 1989-06-01
US40766389A 1989-09-19 1989-09-19
PCT/US1989/004302 WO1990003984A1 (en) 1988-10-03 1989-09-29 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids

Publications (2)

Publication Number Publication Date
DK57391D0 true DK57391D0 (en) 1991-04-02
DK57391A DK57391A (en) 1991-05-29

Family

ID=27400615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK057391A DK57391A (en) 1988-10-03 1991-04-02 HIV PROTEINS AND PEPTIDES FOR USE IN DIAGNOSTICATION, PROPHYLAXY AND TREATMENT OF AIDS

Country Status (10)

Country Link
EP (1) EP0436634A1 (en)
JP (1) JPH04502760A (en)
KR (1) KR900701836A (en)
AU (1) AU640619B2 (en)
DK (1) DK57391A (en)
FI (1) FI911574A0 (en)
IL (1) IL91843A0 (en)
NZ (1) NZ230855A (en)
PT (1) PT91881A (en)
WO (1) WO1990003984A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627798A (en) * 1951-08-27 1953-02-10 William T Graham Clamp for vibrating shank plows
US2712781A (en) * 1952-03-06 1955-07-12 Glencoe Mfg Company Mounting for earth tiller
US2739518A (en) * 1952-04-19 1956-03-27 Glencoe Mfg Company Shank holder
US2775181A (en) * 1953-08-17 1956-12-25 Int Harvester Co Spring mounted tool shank
US3461971A (en) * 1966-07-05 1969-08-19 American Tractor Equip Corp Vyba mount
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
PT94276A (en) * 1989-06-05 1991-02-08 MONOCLONAL ANTIBODY ABLE TO NEUTRALIZ THE HIV PROTOTYPE MN
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
CA2082806A1 (en) * 1990-06-08 1991-12-09 James R. Rusche Immunoassays for anti-hiv-1 antibodies
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (en) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 Monoclonal antibody
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
CA2047033A1 (en) * 1990-07-19 1992-01-20 Elizabeth E. Sugg Cyclic hiv principal neutralizing determinant peptides
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
IT1244529B (en) * 1991-01-30 1994-07-15 Ist Superiore Sanita SYNTHETIC PEPTIDES SUITABLE TO ENHANCE THE INFECTIVITY OF THE HIV-1 VIRUS
JPH05508165A (en) * 1991-04-02 1993-11-18 アルバート・アインシュタイン・カレッジ・オブ・メディシン・オブ・イェシーバ・ユニバーシティー Vaccines for the treatment and prevention of HIV
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
JPH0570493A (en) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst Immune prepared substance related to human immunodefiency virus (hiv)
US5558865A (en) * 1991-08-22 1996-09-24 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
EP0728015B1 (en) 1992-06-18 2006-03-08 Creagen, Inc. Method of producing a set of combinatorial polypeptide antigens
EP0588750A3 (en) * 1992-08-05 1995-01-11 Cigb Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv.
FR2694938B1 (en) * 1992-08-10 1996-11-15 Zagury Jean Francois NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM.
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US5563032A (en) * 1992-10-21 1996-10-08 The United States Of America As Represented By The Department Of Health And Human Services Mosaic polypeptide and methods for detecting the hepatitis E virus
WO1994018232A1 (en) * 1993-02-12 1994-08-18 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
ATE256751T1 (en) * 1993-03-11 2004-01-15 Chemo Sero Therapeut Res Inst MONOCLONAL ANTI-HIV ANTIBODIES
US5864027A (en) 1993-06-07 1999-01-26 Genentech, Inc. HIV envelope polypeptides
US6080429A (en) * 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
US6585979B1 (en) * 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US6602705B1 (en) 1998-12-31 2003-08-05 Chiron Corporation Expression of HIV polypeptides and production of virus-like particles
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
JP4776075B2 (en) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Modified HIVENV polypeptide
AU785319B2 (en) * 1999-09-16 2007-01-11 Eisai Inc. Nucleic acids encoding polyepitope polypeptides
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
AU2002316578A1 (en) 2001-08-31 2003-03-18 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
KR100466382B1 (en) * 2002-01-08 2005-01-14 주식회사 엘지생명과학 Recombinant combo protein fused in HIV type-1 and -2, manufacturing method thereof, vector, transformant and diagnostic kit thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689941D1 (en) * 1985-10-24 1994-08-04 Southwest Found Biomed Res SYNTHETIC PEPTIDES AND THEIR USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
DE3787002T2 (en) * 1986-12-30 1993-11-25 Us Health Synthetic peptides that generate cellular immunity to the AIDS virus and its proteins.
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
FR2619012B1 (en) * 1987-08-07 1989-12-22 Pasteur Institut VACCINES IN WHICH THE CHARACTERISTIC EPITOPE IS INCORPORATED IN A PROTEIN OF PICORNAVIRUS, ESPECIALLY POLIOVIRUS
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
NL8702403A (en) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund OLIGOPEPTIDES AND THEIR USE FOR DIAGNOSTIC AND VACCINATION PURPOSES FOR AIDS AND ARC.

Also Published As

Publication number Publication date
KR900701836A (en) 1990-12-04
NZ230855A (en) 1994-10-26
AU640619B2 (en) 1993-09-02
EP0436634A1 (en) 1991-07-17
PT91881A (en) 1990-04-30
DK57391A (en) 1991-05-29
JPH04502760A (en) 1992-05-21
FI911574A0 (en) 1991-04-02
IL91843A0 (en) 1990-06-10
AU4403689A (en) 1990-05-01
WO1990003984A1 (en) 1990-04-19

Similar Documents

Publication Publication Date Title
DK57391D0 (en) HIV PROTEINS AND PEPTIDES FOR USE IN DIAGNOSTICATION, PROPHYLAXY AND TREATMENT OF AIDS
DK328387D0 (en) PROCEDURE FOR GENETIC MODIFICATION OF YEARS AND 2-MY-M PLASMID VECTOR FOR USE IN THE PROCEDURE
DK512286D0 (en) PROCEDURE FOR PREPARING PEPTIDES AND METHOD FOR USING THE PROCEDURE
DK470489A (en) PROCEDURE FOR PURIFICATION AND FOLDING OF RECOMBINANT PROTEINS
DK21789A (en) CONCENTRATES OF COAGULATING FACTORS II, VII, IX AND X, PROCEDURE FOR THEIR PREPARATION AND APPLICATION OF THEREOF
DK169986A (en) THE ANTIGEN RELATED TO THE GLYCOPROTEIN IN AIDS VIRUS, ISA PRESIDENT FOR THE GLYCOPROTEIN AND PROCEDURE FOR THE PREPARATION OF SUCH ANTIGEN
DK396187D0 (en) DI- AND TRIPEPTIDES, THEIR PREPARATION AND USE
DK476688A (en) HIV PROTEINS AND PEPTIDES USED FOR AIDS DIAGNOSIS, PROPHYLAXY AND THERAPY
NO873216D0 (en) RECOMBINANT HTLV-III PROTEINS AND USE THEREOF.
DK272189D0 (en) HEPATITIVE B VIRUS PROTEIN, PROCEDURES FOR PREPARING THEREOF AND MANUFACTURING USE IN PREPARATION
DK278289D0 (en) EXPRESSION VECTORS, THEIR PREPARATION AND USE OF THE MANUFACTURE OF UNFUSED PROTEINS IN MICRO-ORGANISMS
DK341489D0 (en) PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR THE USE OF BIOLOGICAL ACTIVE PEPTIDES FOR RECTAL AND VAGINAL PURPOSES
DK698188D0 (en) PEPTIDES, THEIR PREPARATION AND USE
DK643188D0 (en) EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
NO890816L (en) DEEMULATING MIXTURES AND PROCEDURES IN THE PREPARATION AND APPLICATION OF THEREOF.
DK604589A (en) PEPTIDES AND THE ANALYSIS OF CONTENT OF SUCH RELATIONS
DK62690A (en) SDK PEPTIDES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATION CONTAINING THESE
DK454088A (en) RECOMBINANT, UNTREATED HIV-1 PROTEINS AND THEIR USE
NO901087D0 (en) CERAMIC BEARS AND PROCEDURES IN THEIR PREPARATION.
DK661489A (en) EXPRESSION PLASMIDS FOR EXPRESSION OF PROTEINS IN E. COLI AND THEIR USE
DK365489D0 (en) PROCEDURE FOR DIAGNOSIS OF HIV INFECTION AND DIAGNOSIS APPLICATION FOR USING THE PROCEDURE
DK604689A (en) PEPTIDES AND THE ANALYSIS OF CONTENT OF SUCH RELATIONS
DK148389D0 (en) PROCEDURE FOR THE PREPARATION OF POLYDICHLORPHOSPHAZENE PREPARATIONS AND THE PREPARATIONS OF THE PROCEDURE
DK266187A (en) RECOMBINANT HUMANT PROTEIN S, METHOD OF PRODUCING IT AND RECOMBINANT DNA VECTOR FOR USE IN THE PROCEDURE
IE881635L (en) Human immunodeficiency virus gag-encoded proteins